Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E P Alyea

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusionL H Sehn, E P Alyea, E Weller, et al.
Bone Marrow Transplantation|March 29, 2000
Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusionE Orsini, E P Alyea, R Schlossman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemiaG Pichert, D C Roy, R Gonin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 5, 2000
Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myelomaE Orsini, E P Alyea, A Chillemi, et al.
Transplantation|May 26, 2001
A CD4+ T cell clone selected from a CML patient after donor lymphocyte infusion recognizes BCR-ABL breakpoint peptides but not tumor cellsE Zorn, E Orsini, C J Wu, et al.
Bone Marrow Transplantation|June 15, 2007
Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancyA M Saito, D Zahrieh, C Cutler, et al.
The Journal of Clinical Investigation|August 15, 1997
Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusionE J Claret, E P Alyea, E Orsini, et al.
Blood|June 20, 1998
Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplantE P Alyea, R J Soiffer, C Canning, et al.
The Journal of Clinical Investigation|September 7, 2000
Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemiaC J Wu, X F Yang, S McLaughlin, et al.
Bone Marrow Transplantation|February 16, 2010
Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapyP Armand, H T Kim, E Mayer, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusionL H Sehn, E P Alyea, E Weller, et al.
Bone Marrow Transplantation|March 29, 2000
Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusionE Orsini, E P Alyea, R Schlossman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemiaG Pichert, D C Roy, R Gonin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 5, 2000
Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myelomaE Orsini, E P Alyea, A Chillemi, et al.
Transplantation|May 26, 2001
A CD4+ T cell clone selected from a CML patient after donor lymphocyte infusion recognizes BCR-ABL breakpoint peptides but not tumor cellsE Zorn, E Orsini, C J Wu, et al.
Bone Marrow Transplantation|June 15, 2007
Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancyA M Saito, D Zahrieh, C Cutler, et al.
The Journal of Clinical Investigation|August 15, 1997
Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusionE J Claret, E P Alyea, E Orsini, et al.
Blood|June 20, 1998
Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplantE P Alyea, R J Soiffer, C Canning, et al.
The Journal of Clinical Investigation|September 7, 2000
Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemiaC J Wu, X F Yang, S McLaughlin, et al.
Bone Marrow Transplantation|February 16, 2010
Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapyP Armand, H T Kim, E Mayer, et al.
Pageof 4